A Screening Instrument to Measure the Prevalence of Neurological Disability in Resource-Poor Settings

被引:14
作者
Bower, James H. [1 ]
Howlett, William [2 ]
Maro, Venance P. [2 ]
Wangai, Hannah [3 ]
Sirima, Neema [3 ]
Reyburn, Hugh [3 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55902 USA
[2] London Sch Hyg & Trop Med, Kilimanjaro Christian Med Ctr, Moshi, Tanzania
[3] London Sch Hyg & Trop Med, Joint Malaria Project, Moshi, Tanzania
关键词
Neurological disability; prevalence; Resource-poor settings; Africa; Community-based study; Neurological impairment; TO-DOOR SURVEY; NEUROEPIDEMIOLOGICAL SURVEY; RISK-FACTORS; POPULATION; DISORDERS; DISEASES; BURDEN; AFRICA; INDIA; URBAN;
D O I
10.1159/000209265
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Very little is known about the prevalence of neurological morbidity in Africa. Much of this is due to the difficulty in performing epidemiological surveys in these settings. A screening instrument to measure neurological disease in resource-poor settings was designed by the World Health Organization in 1981, but several problems with it have subsequently been recognized. Methods: We created a new screening instrument that addressed problems with the original instrument identified by prior investigators, and that included questions to identify diseases of public health significance and broad neurological syndromes. This new instrument was tested in an outpatient setting in Moshi, Tanzania. We compared the sensitivity and specificity of the new instrument to the original 1981 WHO instrument. Results: We tested the survey on 128 participants. Of these, 63 had neurological diagnoses, 21 had pain-only diagnoses and 44 had no neurological diagnoses. The survey was well received by all the participants. A nonmedical interviewer was trained to administer and interpret a simple neurological examination without difficulty. The median time to administer the instrument was 13 min (interquartile range 10-17 min). The sensitivity of the new instrument improved that of the WHO instrument from 98.4 to 100%, but the difference was not statistically significant (p = 0.44). However, the specificity significantly improved from 29.2 to 61.0% (p = 0.001). Conclusions: We have developed a screening instrument to measure the prevalence of neurological morbidity in resource-poor settings. It was shown to be highly feasible, highly sensitive, and more specific than the existing WHO instrument. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:313 / 320
页数:8
相关论文
共 32 条
[1]   Pitfalls in neuroepidemiologic research [J].
Anderson, DW ;
Rocca, WA ;
Rosário, JA .
NEUROEPIDEMIOLOGY, 1998, 17 (02) :55-62
[2]  
[Anonymous], 2003, Note for guidance on stability testing: stability testing of new drug substances and products, P1
[3]  
[Anonymous], 2006, NEUR DIS PUBL HLTH C, P1
[4]  
BEKELE G, 1990, ETHIOPIAN MED J, V28, P23
[5]   Epilepsy prevalence in rural Zambia: a door-to-door survey [J].
Birbeck, GL ;
Kalichi, EMN .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (01) :92-95
[6]   The burden of inpatient neurologic disease in two Ethiopian hospitals [J].
Bower, J. H. ;
Asmera, J. ;
Zebenigus, M. ;
Sandroni, P. ;
Bower, S. M. ;
Zenebe, G. .
NEUROLOGY, 2007, 68 (05) :338-342
[7]   Neurologic services in the nations of Africa [J].
Bower, JH ;
Zenebe, G .
NEUROLOGY, 2005, 64 (03) :412-415
[8]   A neuroepidemiological study in Beira, Mozambique [J].
Casanova-Sotolongo, P ;
Casanova-Carrillo, P ;
Rodríguez-Costa, J .
REVISTA DE NEUROLOGIA, 2000, 30 (12) :1135-1140
[9]   Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? [J].
Cooper, RS ;
Osotimehin, B ;
Kaufman, JS ;
Forrester, T .
LANCET, 1998, 351 (9097) :208-210
[10]  
Cowppli-Bony Pascale, 2004, Sante, V14, P173